On Thursday June 9th from 10:30 to 11:30pm in Room 124 North Mike May and I will be going over the […]
Get your Worldview on — Measuring Global Biotechnology at #BIO2016 Read Post »
My book signing sold out, but do not despair — you can still get a signed copy. Signed copies of Building
I will be signing my textbook Building Biotechnology, and other books, in the BIO bookstore on Wednesday June 8th from 12:30 pm
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s
Biotech in Countries Starting with “I” – Part 10: India Read Post »
This is a guest post from Robert Yapundich, MD and Gregory Schimizzi, MD. Dr. Yapundich is a practicing neurologist in Hickory, North Carolina and a
Biosimilar Naming: Distinguishable or Disingenuous? Read Post »
[slideshare id=61425574&doc=whendodrugpatentsexpire-160427163211] When do drug patents expire, and when can generic drugs launch? An overview of patents, non-patent regulatory exclusivities,
When do Drug Patents Expire, and When Can Generic Drugs Launch? Read Post »
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s
New Dosage Forms are one of the categories for which the FDA grants three years of exclusivity for ‘New Clinical
Which pharmaceutical companies have the most “New Dosage Form” drugs? Read Post »
New Dosage Forms are one of the categories for which the FDA grants three years of exclusivity for ‘New Clinical
Which pharma companies have the most ‘New Dosage Form’ exclusivities? Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Bioentrepreneurship education programmes in the United States
Go to paperABSTRACT: In this first paper of a new regular column, Arlen Meyers and Patrick…
Bioentrepreneurship education programmes in the United States Read Post »
Get new actionable insights and updates from BiotechBlog
